Cargando…
Suppression of tumor metastasis by a RECK-activating small molecule
RECK encodes a membrane-anchored protease-regulator which is often downregulated in a wide variety of cancers, and reduced RECK expression often correlates with poorer prognoses. In mouse models, forced expression of RECK in tumor xenografts results in suppression of tumor angiogenesis, invasion, an...
Autores principales: | Yoshida, Yoko, Yuki, Kanako, Dan, Shingo, Yamazaki, Kanami, Noda, Makoto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837781/ https://www.ncbi.nlm.nih.gov/pubmed/35149728 http://dx.doi.org/10.1038/s41598-022-06288-3 |
Ejemplares similares
-
Bioinformatic Studies to Predict MicroRNAs with the Potential of Uncoupling RECK Expression from Epithelial–Mesenchymal Transition in Cancer Cells
por: Wang, Zhipeng, et al.
Publicado: (2016) -
A novel screen using the Reck tumor suppressor gene promoter detects both conventional and metastasis-suppressing anticancer drugs
por: Murai, Ryuya, et al.
Publicado: (2010) -
E-cadherin–downregulation and RECK-upregulation are coupled in the non-malignant epithelial cell line MCF10A but not in multiple carcinoma-derived cell lines
por: Yuki, Kanako, et al.
Publicado: (2014) -
Pattern of RECK CpG methylation as a potential marker for predicting breast cancer prognosis and drug-sensitivity
por: Shi, Gongping, et al.
Publicado: (2016) -
The RECK tumor-suppressor protein binds and stabilizes ADAMTS10
por: Matsuzaki, Tomoko, et al.
Publicado: (2018)